+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

mRNA Synthesis Raw Materials Market Size, Share & Trends Analysis Report by Type (Capping Agents, Nucleotides), Application (Vaccine Production, Therapeutics Production), End-use, Region, and Segment Forecasts, 2024-2030

  • PDF Icon

    Report

  • 120 Pages
  • June 2024
  • Region: Global
  • Grand View Research
  • ID: 5734438
Description Jump to:
The global mRNA synthesis raw materials market size is projected to reach USD 1.99 billion by 2030. The market is expected to expand at a CAGR of 2.85% from 2024 to 2030. The major factors driving the market growth include growing academic and industrial interest in mRNA technology, the advantages of mRNA vaccines, and increasing funding for research. In addition, the increasing therapeutic applications of RNA technology are projected to offer lucrative opportunities for the mRNA synthesis raw materials market during the forecast period.

The COVID-19 pandemic has increased the demand for mRNA synthesis raw materials for developing an efficient vaccine to battle infectious diseases. mRNA vaccines are a safe and efficient method for preventing COVID-19. In addition, the advantages associated with the mRNA COVID-19 vaccines have sparked the attention of pharmaceutical businesses in delivering vaccines swiftly across the globe. For instance, the National Institute of Allergy and Infectious Diseases and Moderna, Inc. mutually developed the mRNA-1273 (NIAID) in March 2020. As a result, the usage of mRNA vaccines increased significantly during the COVID-19 pandemic.

Furthermore, many major pharmaceutical firms have started working on mRNA-based therapeutics, including Novartis, Alexion, AstraZeneca, Pfizer, Sanofi Pasteur, and Shire. For instance, in January 2022, according to a development and option agreement between Pfizer Inc. and Acuitas Therapeutics, Pfizer will have the option to license Acuitas' LNP technology for up to 10 targets for the development of mRNA therapeutics & vaccines. Therefore, the adoption rate of mRNA synthesis raw materials has increased among pharma & biotech companies, which further fuels the market growth.

Moreover, due to the temporary nature of mRNA translation and lack of integration of the foreign material into the cell's genome, the resulting cellular therapeutic product has a number of benefits over the one obtained by a more conventional approach. Some of the advantages include easier production under acceptable manufacturing procedures, reduced cytotoxicity from on-target off-tumor effects, and better clinical validation and regulatory treatment. Thus, such advantages are expected to increase the demand for mRNA therapeutics and further boost market growth.

Additionally, regarding the treatment and prevention of several diseases, mRNA-based technologies have been proven to be incredibly promising. Tremendous advances in technology and scientific study over the past ten years have made mRNA a feasible therapeutic option, eliminating some of the problems with its use, such as its brief half-life and innate immunogenicity. For instance, as mRNA technology advances, its fusion with new adoptive immunotherapies may result in safer and more efficient methods, such as the creation of cutting-edge chimeric antigen receptor T-cells. Therefore, advancements in mRNA technology are projected to open new avenues for market growth.

However, the high cost of raw materials may impede the market during the study period. For instance, the purchase price of raw materials, such as CleanCap AG, accounts for around 45% of the total raw material costs incurred while producing both vaccines. In addition, the regulatory framework pertaining to approval processes has always been the most critical restraining factor in the biotechnology, pharmaceutical, and medical technology industry. The absence of effective regulatory framework/guidelines for the therapeutic sector in developing countries such as China and India, where the mRNA synthesis raw materials market holds great growth potential due to the presence of a large patient base, is anticipated to impede the market growth in the coming years.

mRNA Synthesis Raw Materials Market Report Highlights

  • The capping agents segment held the largest share of 39.17% in 2023 owing to the advancements in the capping technology and their applications in the biopharma industry and research
  • By application, The vaccine production segment dominated the global industry with the largest revenue share in 2023. This can be attributed to the rapid production of mRNA vaccines compared to the conventional vaccines that utilize cell-culture-based production paths, which are often prone to failure.
  • North America dominated the global industry in 2023 and accounted for the largest share of more than 36.77% of the overall revenue in 2023, and is expected to grow at the highest CAGR over the forecast period.
  • The biopharmaceutical and pharmaceutical companies segment dominated the market with the highest revenue share in 2023, due to the high commercial success of biopharmaceuticals and rapid growth in demand for therapeutics.

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players worldwide.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets


This product will be delivered within 2 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Type
1.2.2. Application
1.2.3. End-use
1.3. Information analysis
1.4. Market formulation & data visualization
1.5. Data validation & publishing
1.6. Information Procurement
1.6.1. Primary Research
1.7. Information or Data Analysis
1.8. Market Formulation & Validation
1.9. Market Model
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Growing academic and industrial interest in mRNA technology
3.2.1.2. Advantages of mRNA vaccines
3.2.1.3. Increasing funding for mRNA research
3.2.2. Market Restraint Analysis
3.2.2.1. Nonexistence of effective government regulations for mRNA - based product approvals
3.2.2.2. High cost of mRNA synthesis raw materials
3.3. Industry Analysis Tools
3.3.1. Porter's Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. mRNA Synthesis Raw Materials Market: Type Business Analysis
4.1. Type Segment Dashboard
4.2. Global mRNA Synthesis Raw Materials Market Type Movement Analysis
4.3. Global mRNA Synthesis Raw Materials Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
4.4. Capping Agents
4.4.1. Global Capping Agents Market Estimates and Forecasts, 2018-2030 (USD Million)
4.5. Nucleotides
4.5.1. Global Nucleotides Market Estimates and Forecasts, 2018-2030 (USD Million)
4.6. Plasmid DNA
4.6.1. Global Plasmid DNA Market Estimates and Forecasts, 2018-2030 (USD Million)
4.7. Enzymes
4.7.1. Global Enzymes Market Estimates and Forecasts, 2018-2030 (USD Million)
4.7.2. Polymerase
4.7.2.1. Global Polymerase Market Estimates and Forecasts, 2018-2030 (USD Million)
4.7.3. RNase Inhibitor
4.7.3.1. Global RNase Inhibitor Market Estimates and Forecasts, 2018-2030 (USD Million)
4.7.4. DNase
4.7.4.1. Global DNase Market Estimates and Forecasts, 2018-2030 (USD Million)
4.7.5. Others
4.7.5.1. Global Others Market Estimates and Forecasts, 2018-2030 (USD Million)
4.8. Others
4.8.1. Global Others Market Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 5. mRNA Synthesis Raw Materials Market: Application Business Analysis
5.1. Application Segment Dashboard
5.2. Global mRNA Synthesis Raw Materials Market Application, Movement Analysis
5.3. Global mRNA Synthesis Raw Materials Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
5.4. Therapeutics Production
5.4.1. Global Therapeutics Production Market Estimates and Forecasts, 2018-2030 (USD Million)
5.5. Vaccine Production
5.5.1. Global Vaccine ProductionMarket Estimates and Forecasts, 2018-2030 (USD Million)
5.6. Others
5.6.1. Global Others Market Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 6. mRNA Synthesis Raw Materials Market: End-use Business Analysis
6.1. End-use Segment Dashboard
6.2. Global mRNA Synthesis Raw Materials Market End-use Movement Analysis
6.3. Global mRNA Synthesis Raw Materials Market Size & Trend Analysis, by End-use, 2018 to 2030 (USD Million)
6.4. Biopharmaceutical & Pharmaceutical Companies
6.4.1. Global Biopharmaceutical & Pharmaceutical Companies Market Estimates and Forecasts, 2018-2030 (USD Million)
6.5. CROs & CMOs
6.5.1. Global CROs & CMOs Market Estimates and Forecasts, 2018-2030 (USD Million)
6.6. Academic & Research Institutions
6.6.1. Global Academic & Research Institutions Market Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 7. mRNA Synthesis Raw Materials Market: Regional Estimates & Trend Analysis by Type, Application, and End-use
7.1. Regional Dashboard
7.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
7.3. North America
7.3.1. North America MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018-2030 (USD Million)
7.3.2. U.S.
7.3.2.1. Key Country Dynamics
7.3.2.2. Competitive Scenario
7.3.2.3. Regulatory Framework
7.3.2.4. U.S. MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018-2030 (USD Million)
7.3.3. Canada
7.3.3.1. Key Country Dynamics
7.3.3.2. Competitive Scenario
7.3.3.3. Regulatory Framework
7.3.3.4. Canada MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018-2030 (USD Million)
7.3.4. Mexico
7.3.4.1. Key Country Dynamics
7.3.4.2. Competitive Scenario
7.3.4.3. Regulatory Framework
7.3.4.4. Mexico MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018-2030 (USD Million)
7.4. Europe
7.4.1. Europe MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018-2030 (USD Million)
7.4.2. UK
7.4.2.1. Key Country Dynamics
7.4.2.2. Competitive Scenario
7.4.2.3. Regulatory Framework
7.4.2.4. UK MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018-2030 (USD Million)
7.4.3. Germany
7.4.3.1. Key Country Dynamics
7.4.3.2. Competitive Scenario
7.4.3.3. Regulatory Framework
7.4.3.4. Germany MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018-2030 (USD Million)
7.4.4. France
7.4.4.1. Key Country Dynamics
7.4.4.2. Competitive Scenario
7.4.4.3. Regulatory Framework
7.4.4.4. France MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018-2030 (USD Million)
7.4.5. Italy
7.4.5.1. Key Country Dynamics
7.4.5.2. Competitive Scenario
7.4.5.3. Regulatory Framework
7.4.5.4. Italy MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018-2030 (USD Million)
7.4.6. Spain
7.4.6.1. Key Country Dynamics
7.4.6.2. Competitive Scenario
7.4.6.3. Regulatory Framework
7.4.6.4. Spain MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018-2030 (USD Million)
7.4.7. Denmark
7.4.7.1. Key Country Dynamics
7.4.7.2. Competitive Scenario
7.4.7.3. Regulatory Framework
7.4.7.4. Denmark MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018-2030 (USD Million)
7.4.8. Sweden
7.4.8.1. Key Country Dynamics
7.4.8.2. Competitive Scenario
7.4.8.3. Regulatory Framework
7.4.8.4. Sweden MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018-2030 (USD Million)
7.4.9. Norway
7.4.9.1. Key Country Dynamics
7.4.9.2. Competitive Scenario
7.4.9.3. Regulatory Framework
7.4.9.4. Norway MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018-2030 (USD Million)
7.5. Asia Pacific
7.5.1. Asia Pacific MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018-2030 (USD Million)
7.5.2. Japan
7.5.2.1. Key Country Dynamics
7.5.2.2. Competitive Scenario
7.5.2.3. Regulatory Framework
7.5.2.4. Japan MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018-2030 (USD Million)
7.5.3. China
7.5.3.1. Key Country Dynamics
7.5.3.2. Competitive Scenario
7.5.3.3. Regulatory Framework
7.5.3.4. China MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018-2030 (USD Million)
7.5.4. India
7.5.4.1. Key Country Dynamics
7.5.4.2. Competitive Scenario
7.5.4.3. Regulatory Framework
7.5.4.4. India MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018-2030 (USD Million)
7.5.5. Australia
7.5.5.1. Key Country Dynamics
7.5.5.2. Competitive Scenario
7.5.5.3. Regulatory Framework
7.5.5.4. Australia MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018-2030 (USD Million)
7.5.6. Thailand
7.5.6.1. Key Country Dynamics
7.5.6.2. Competitive Scenario
7.5.6.3. Regulatory Framework
7.5.6.4. Thailand MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018-2030 (USD Million)
7.5.7. South Korea
7.5.7.1. Key Country Dynamics
7.5.7.2. Competitive Scenario
7.5.7.3. Regulatory Framework
7.5.7.4. South Korea MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018-2030 (USD Million)
7.6. Latin America
7.6.1. Latin America MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018-2030 (USD Million)
7.6.2. Brazil
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Regulatory Framework
7.6.2.4. Brazil MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018-2030 (USD Million)
7.6.3. Argentina
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Regulatory Framework
7.6.3.4. Argentina MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018-2030 (USD Million)
7.7. MEA
7.7.1. MEA MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018-2030 (USD Million)
7.7.2. South Africa
7.7.2.1. Key Country Dynamics
7.7.2.2. Competitive Scenario
7.7.2.3. Regulatory Framework
7.7.2.4. South Africa MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018-2030 (USD Million)
7.7.3. Saudi Arabia
7.7.3.1. Key Country Dynamics
7.7.3.2. Competitive Scenario
7.7.3.3. Regulatory Framework
7.7.3.4. Saudi Arabia MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018-2030 (USD Million)
7.7.4. UAE
7.7.4.1. Key Country Dynamics
7.7.4.2. Competitive Scenario
7.7.4.3. Regulatory Framework
7.7.4.4. UAE MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018-2030 (USD Million)
7.7.5. Kuwait
7.7.5.1. Key Country Dynamics
7.7.5.2. Competitive Scenario
7.7.5.3. Regulatory Framework
7.7.5.4. Kuwait MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Participant Categorization
8.2. Strategy Mapping
8.3. Company Market Position Analysis, 2023
8.4. Participant’s Overview
8.4.1. F. Hoffmann - La Roche Ltd.
8.4.1.1. Overview
8.4.1.2. Financial Performance
8.4.1.3. Product Benchmarking
8.4.1.4. Strategic Initiatives
8.4.2. Jena Bioscience Gmbh
8.4.2.1. Overview
8.4.2.2. Financial Performance
8.4.2.3. Product Benchmarking
8.4.2.4. Strategic Initiatives
8.4.3. Merck KGaA
8.4.3.1. Overview
8.4.3.2. Financial Performance
8.4.3.3. Product Benchmarking
8.4.3.4. Strategic Initiatives
8.4.4. Yeasen Biotechnology (Shanghai) Co.,Ltd.
8.4.4.1. Overview
8.4.4.2. Financial Performance
8.4.4.3. Product Benchmarking
8.4.4.4. Strategic Initiatives
8.4.5. BOC Sciences
8.4.5.1. Overview
8.4.5.2. Financial Performance
8.4.5.3. Product Benchmarking
8.4.5.4. Strategic Initiatives
8.4.6. Thermo Fisher Scientific, Inc.
8.4.6.1. Overview
8.4.6.2. Financial Performance
8.4.6.3. Product Benchmarking
8.4.6.4. Strategic Initiatives
8.4.7. Maravai Lifesciences
8.4.7.1. Overview
8.4.7.2. Financial Performance
8.4.7.3. Product Benchmarking
8.4.7.4. Strategic Initiatives
8.4.8. New England Biolabs
8.4.8.1. Overview
8.4.8.2. Financial Performance
8.4.8.3. Product Benchmarking
8.4.8.4. Strategic Initiatives
8.4.9. Creative Biogene
8.4.9.1. Overview
8.4.9.2. Financial Performance
8.4.9.3. Product Benchmarking
8.4.9.4. Strategic Initiatives
8.4.10. Hongene
8.4.10.1. Overview
8.4.10.2. Financial Performance
8.4.10.3. Product Benchmarking
8.4.10.4. Strategic Initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global mRNA synthesis raw materials market, by type, 2018-2030 (USD Million)
Table 4 Global mRNA synthesis raw materials market, by application, 2018-2030 (USD Million)
Table 5 Global mRNA synthesis raw materials market, by End - use, 2018-2030 (USD Million)
Table 6 Global mRNA synthesis raw materials market, by region, 2018-2030 (USD Million)
Table 7 North America mRNA synthesis raw materials market, by country, 2018-2030 (USD Million)
Table 8 North America mRNA synthesis raw materials market, by type, 2018-2030 (USD Million)
Table 9 North America mRNA synthesis raw materials market, by application, 2018-2030 (USD Million)
Table 10 North America mRNA synthesis raw materials market, by end - use, 2018-2030 (USD Million)
Table 11 U.S. mRNA synthesis raw materials market, by type, 2018-2030 (USD Million)
Table 12 U.S. mRNA synthesis raw materials market, by application, 2018-2030 (USD Million)
Table 13 U.S. mRNA synthesis raw materials market, by end - use, 2018-2030 (USD Million)
Table 14 Canada mRNA synthesis raw materials market, by type, 2018-2030 (USD Million)
Table 15 Canada mRNA synthesis raw materials market, by application, 2018-2030 (USD Million)
Table 16 Canada mRNA synthesis raw materials market, by end - use, 2018-2030 (USD Million)
Table 17 Europe mRNA synthesis raw materials market, by country, 2018-2030 (USD Million)
Table 18 Europe mRNA synthesis raw materials market, by type, 2018-2030 (USD Million)
Table 19 Europe mRNA synthesis raw materials market, by application, 2018-2030 (USD Million)
Table 20 Europe mRNA synthesis raw materials market, by end - use, 2018-2030 (USD Million)
Table 21 UK mRNA synthesis raw materials market, by type, 2018-2030 (USD Million)
Table 22 UK mRNA synthesis raw materials market, by application, 2018-2030 (USD Million)
Table 23 UK mRNA synthesis raw materials market, by end - use, 2018-2030 (USD Million)
Table 24 Germany mRNA synthesis raw materials market, by type, 2018-2030 (USD Million)
Table 25 Germany mRNA synthesis raw materials market, by application, 2018-2030 (USD Million)
Table 26 Germany mRNA synthesis raw materials market, by end - use, 2018-2030 (USD Million)
Table 27 France mRNA synthesis raw materials market, by type, 2018-2030 (USD Million)
Table 28 France mRNA synthesis raw materials market, by application, 2018-2030 (USD Million)
Table 29 France mRNA synthesis raw materials market, by end - use, 2018-2030 (USD Million)
Table 30 Italy mRNA synthesis raw materials market, by type, 2018-2030 (USD Million)
Table 31 Italy mRNA synthesis raw materials market, by application, 2018-2030 (USD Million)
Table 32 Italy mRNA synthesis raw materials market, by end - use, 2018-2030 (USD Million)
Table 33 Spain mRNA synthesis raw materials market, by type, 2018-2030 (USD Million)
Table 34 Spain mRNA synthesis raw materials market, by application, 2018-2030 (USD Million)
Table 35 Spain mRNA synthesis raw materials market, by end - use, 2018-2030 (USD Million)
Table 36 Denmark mRNA synthesis raw materials market, by type, 2018-2030 (USD Million)
Table 37 Denmark mRNA synthesis raw materials market, by application, 2018-2030 (USD Million)
Table 38 Denmark mRNA synthesis raw materials market, by end - use, 2018-2030 (USD Million)
Table 39 Sweden mRNA synthesis raw materials market, by type, 2018-2030 (USD Million)
Table 40 Sweden mRNA synthesis raw materials market, by application, 2018-2030 (USD Million)
Table 41 Sweden mRNA synthesis raw materials market, by end - use, 2018-2030 (USD Million)
Table 42 Norway mRNA synthesis raw materials market, by type, 2018-2030 (USD Million)
Table 43 Norway mRNA synthesis raw materials market, by application, 2018-2030 (USD Million)
Table 44 Norway mRNA synthesis raw materials market, by end - use, 2018-2030 (USD Million)
Table 45 Asia Pacific mRNA synthesis raw materials market, by country, 2018-2030 (USD Million)
Table 46 Asia Pacific mRNA synthesis raw materials market, by type, 2018-2030 (USD Million)
Table 47 Asia Pacific mRNA synthesis raw materials market, by application, 2018-2030 (USD Million)
Table 48 Asia Pacific mRNA synthesis raw materials market, by end - use, 2018-2030 (USD Million)
Table 49 Japan mRNA synthesis raw materials market, by type, 2018-2030 (USD Million)
Table 50 Japan mRNA synthesis raw materials market, by application, 2018-2030 (USD Million)
Table 51 Japan mRNA synthesis raw materials market, by end - use, 2018-2030 (USD Million)
Table 52 China mRNA synthesis raw materials market, by type, 2018-2030 (USD Million)
Table 53 China mRNA synthesis raw materials market, by application, 2018-2030 (USD Million)
Table 54 China mRNA synthesis raw materials market, by end - use, 2018-2030 (USD Million)
Table 55 India mRNA synthesis raw materials market, by type, 2018-2030 (USD Million)
Table 56 India mRNA synthesis raw materials market, by application, 2018-2030 (USD Million)
Table 57 India mRNA synthesis raw materials market, by end - use, 2018-2030 (USD Million)
Table 58 Australia mRNA synthesis raw materials market, by type, 2018-2030 (USD Million)
Table 59 Australia mRNA synthesis raw materials market, by application, 2018-2030 (USD Million)
Table 60 Australia mRNA synthesis raw materials market, by end - use, 2018-2030 (USD Million)
Table 61 Thailand mRNA synthesis raw materials market, by type, 2018-2030 (USD Million)
Table 62 Thailand mRNA synthesis raw materials market, by application, 2018-2030 (USD Million)
Table 63 Thailand mRNA synthesis raw materials market, by end - use, 2018-2030 (USD Million)
Table 64 South Korea mRNA synthesis raw materials market, by type, 2018-2030 (USD Million)
Table 65 South Korea mRNA synthesis raw materials market, by application, 2018-2030 (USD Million)
Table 66 South Korea mRNA synthesis raw materials market, by end - use, 2018-2030 (USD Million)
Table 67 Latin America mRNA synthesis raw materials market, by country, 2018-2030 (USD Million)
Table 68 Latin America mRNA synthesis raw materials market, by type, 2018-2030 (USD Million)
Table 69 Latin America mRNA synthesis raw materials market, by application, 2018-2030 (USD Million)
Table 70 Latin America mRNA synthesis raw materials market, by end - use, 2018-2030 (USD Million)
Table 71 Brazil mRNA synthesis raw materials market, by type, 2018-2030 (USD Million)
Table 72 Brazil mRNA synthesis raw materials market, by application, 2018-2030 (USD Million)
Table 73 Brazil mRNA synthesis raw materials market, by end - use, 2018-2030 (USD Million)
Table 74 Mexico mRNA synthesis raw materials market, by type, 2018-2030 (USD Million)
Table 75 Mexico mRNA synthesis raw materials market, by application, 2018-2030 (USD Million)
Table 76 Mexico mRNA synthesis raw materials market, by end - use, 2018-2030 (USD Million)
Table 77 Argentina mRNA synthesis raw materials market, by type, 2018-2030 (USD Million)
Table 78 Argentina mRNA synthesis raw materials market, by application, 2018-2030 (USD Million)
Table 79 Argentina mRNA synthesis raw materials market, by end - use, 2018-2030 (USD Million)
Table 80 Middle East & Africa mRNA synthesis raw materials market, by country, 2018-2030 (USD Million)
Table 81 Middle East & Africa mRNA synthesis raw materials market, by type, 2018-2030 (USD Million)
Table 82 Middle East & Africa mRNA synthesis raw materials market, by application, 2018-2030 (USD Million)
Table 83 Middle East & Africa mRNA synthesis raw materials market, by end - use, 2018-2030 (USD Million)
Table 84 South Africa mRNA synthesis raw materials market, by type, 2018-2030 (USD Million)
Table 85 South Africa mRNA synthesis raw materials market, by application, 2018-2030 (USD Million)
Table 86 South Africa mRNA synthesis raw materials market, by end - use, 2018-2030 (USD Million)
Table 87 Saudi Arabia mRNA synthesis raw materials market, by type, 2018-2030 (USD Million)
Table 88 Saudi Arabia mRNA synthesis raw materials market, by application, 2018-2030 (USD Million)
Table 89 Saudi Arabia mRNA synthesis raw materials market, by end - use, 2018-2030 (USD Million)
Table 90 UAE mRNA synthesis raw materials market, by type, 2018-2030 (USD Million)
Table 91 UAE mRNA synthesis raw materials market, by application, 2018-2030 (USD Million)
Table 92 UAE mRNA synthesis raw materials market, by end - use, 2018-2030 (USD Million)
Table 93 Kuwait mRNA synthesis raw materials market, by type, 2018-2030 (USD Million)
Table 94 Kuwait mRNA synthesis raw materials market, by application, 2018-2030 (USD Million)
Table 95 Kuwait mRNA synthesis raw materials market, by end - use, 2018-2030 (USD Million)
Table 96 Participant's overview
Table 97 Financial performance
Table 98 Key companies undergoing expansions
Table 99 Key companies undergoing acquisitions
Table 100 Key companies undergoing collaborations
Table 101 Key companies launching new types
Table 102 Key companies undertaking other strategies
List of Figures
Figure 1 mRNA synthesis raw materials market segmentation
Figure 2 Market research process
Figure 3 Data triangulation techniques
Figure 4 Primary research pattern
Figure 5 Market research approaches
Figure 6 Market formulation & validation
Figure 7 Market outlook
Figure 8 Segment snapshot
Figure 9 Competitive landscape snapshot
Figure 10 Parent market outlook
Figure 11 mRNA synthesis raw materials market driver analysis
Figure 12 mRNA synthesis raw materials market restraint analysis
Figure 13 mRNA synthesis raw materials market: Porter's analysis
Figure 14 mRNA synthesis raw materials market: PESTEL analysis
Figure 15 mRNA synthesis raw materials market: Type outlook and key takeaways
Figure 16 mRNA synthesis raw materials market: Type market share analysis, 2023-2030
Figure 17 Global mRNA synthesis raw materials by capping agents market, 2018-2030 (USD Million)
Figure 18 Global mRNA synthesis raw materials by nucleotides market, 2018-2030 (USD Million)
Figure 19 Global mRNA synthesis raw materials by plasmid DNA market, 2018-2030 (USD Million)
Figure 20 Global mRNA synthesis raw materials by enzymes market, 2018-2030 (USD Million)
Figure 21 Global mRNA synthesis raw materials by polymerase market, 2018-2030 (USD Million)
Figure 22 Global mRNA synthesis raw materials by RNase inhibitor market, 2018-2030 (USD Million)
Figure 23 Global mRNA synthesis raw materials by DNase market, 2018-2030 (USD Million)
Figure 24 Global mRNA synthesis raw materials by others market, 2018-2030 (USD Million)
Figure 25 Global mRNA synthesis raw materials by others market, 2018-2030 (USD Million)
Figure 26 mRNA synthesis raw materials market: Application outlook and key takeaways
Figure 27 mRNA synthesis raw materials market: Application market share analysis, 2023-2030
Figure 28 Global mRNA synthesis raw materials by vaccine production market, 2018-2030 (USD Million)
Figure 29 Global mRNA synthesis raw materials by therapeutics production market, 2018-2030 (USD Million)
Figure 30 Global mRNA synthesis raw materials by others market, 2018-2030 (USD Million)
Figure 31 mRNA synthesis raw materials market: End-use outlook and key takeaways
Figure 32 mRNA synthesis raw materials market: End-use market share analysis, 2023-2030
Figure 33 Global mRNA synthesis raw materials by biopharmaceutical & pharmaceutical companies market, 2018-2030 (USD Million)
Figure 34 Global mRNA synthesis raw materials by CROs & CMOs market, 2018-2030 (USD Million)
Figure 35 Global mRNA synthesis raw materials by academic & research institutes market, 2018-2030 (USD Million)
Figure 36 Regional marketplace: Key takeaways
Figure 37 North America mRNA synthesis raw materials market estimates and forecast, 2018-2030 (USD Million)
Figure 38 U.S. mRNA synthesis raw materials market estimates and forecast, 2018-2030 (USD Million)
Figure 39 Canada mRNA synthesis raw materials market, 2018-2030 (USD Million)
Figure 40 Mexico mRNA synthesis raw materials market estimates and forecast, 2018-2030 (USD Million)
Figure 41 Europe mRNA synthesis raw materials market estimates and forecast, 2018-2030 (USD Million)
Figure 42 UK mRNA synthesis raw materials market estimates and forecast, 2018-2030 (USD Million)
Figure 43 Germany mRNA synthesis raw materials market estimates and forecast, 2018-2030 (USD Million)
Figure 44 France mRNA synthesis raw materials market estimates and forecast, 2018-2030 (USD Million)
Figure 45 Italy mRNA synthesis raw materials market estimates and forecast, 2018-2030 (USD Million)
Figure 46 Spain mRNA synthesis raw materials market estimates and forecast, 2018-2030 (USD Million)
Figure 47 Denmark mRNA synthesis raw materials market estimates and forecast, 2018-2030 (USD Million)
Figure 48 Sweden mRNA synthesis raw materials market estimates and forecast, 2018-2030 (USD Million)
Figure 49 Norway mRNA synthesis raw materials market estimates and forecast, 2018-2030 (USD Million)
Figure 50 Asia-Pacific mRNA synthesis raw materials market estimates and forecast, 2018-2030 (USD Million)
Figure 51 Japan mRNA synthesis raw materials market estimates and forecast, 2018-2030 (USD Million)
Figure 52 China mRNA synthesis raw materials market estimates and forecast, 2018-2030 (USD Million)
Figure 53 India mRNA synthesis raw materials market estimates and forecast, 2018-2030 (USD Million)
Figure 54 Australia mRNA synthesis raw materials market estimates and forecast, 2018-2030 (USD Million)
Figure 55 Thailand mRNA synthesis raw materials market estimates and forecast, 2018-2030 (USD Million)
Figure 56 South Korea mRNA synthesis raw materials market estimates and forecast, 2018-2030 (USD Million)
Figure 57 Latin America mRNA synthesis raw materials market estimates and forecast, 2018-2030 (USD Million)
Figure 58 Brazil mRNA synthesis raw materials market estimates and forecast, 2018-2030 (USD Million)
Figure 59 Argentina mRNA synthesis raw materials market estimates and forecast, 2018-2030 (USD Million)
Figure 60 MEA mRNA synthesis raw materials market estimates and forecast, 2018-2030 (USD Million)
Figure 61 South Africa mRNA synthesis raw materials market estimates and forecast, 2018-2030 (USD Million)
Figure 62 Saudi Arabia mRNA synthesis raw materials market estimates and forecast, 2018-2030 (USD Million)
Figure 63 UAE mRNA synthesis raw materials market estimates and forecast, 2018-2030 (USD Million)
Figure 64 Kuwait mRNA synthesis raw materials market estimates and forecast, 2018-2030 (USD Million)
Figure 65 Key company categorization
Figure 66 Company market positioning
Figure 67 Market participant categorization
Figure 68 Strategy framework

Companies Mentioned

  • F. Hoffmann - La Roche Ltd.
  • Jena Bioscience Gmbh
  • Merck KGaA
  • Yeasen Biotechnology (Shanghai) Co.,Ltd.
  • BOC Sciences
  • Thermo Fisher Scientific, Inc.
  • Maravai Lifesciences
  • New England Biolabs
  • Creative Biogene
  • Hongene

Methodology

Loading
LOADING...

Related Topics

Related Reports

Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Global Market Report 2024 - Product Image

Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
mRNA Synthesis and Manufacturing Market: Industry Trends and Global Forecasts, till 2035 - Distribution by Type of Product, Application Area, Therapeutic Area and Key Geographical Regions - Product Image

mRNA Synthesis and Manufacturing Market: Industry Trends and Global Forecasts, till 2035 - Distribution by Type of Product, Application Area, Therapeutic Area and Key Geographical Regions

  • Report
  • 170 Pages
  • Global
From
mRNA Therapeutics Contract Development & Manufacturing Organization Market Size, Share & Trends Analysis Report by Application, Indication, End-use, Region, and Segment Forecasts, 2024-2030 - Product Image

mRNA Therapeutics Contract Development & Manufacturing Organization Market Size, Share & Trends Analysis Report by Application, Indication, End-use, Region, and Segment Forecasts, 2024-2030

  • Report
  • 144 Pages
  • Global
From
mRNA Synthesis & Manufacturing Market by Product (Consumables [Transcription, Purification, Analysis & Characterization], Instrument), Service (Synthesis, Purification, Manufacturing & Scale-up), Application (CGT, Vaccines) - Global Forecast to 2029 - Product Image

mRNA Synthesis & Manufacturing Market by Product (Consumables [Transcription, Purification, Analysis & Characterization], Instrument), Service (Synthesis, Purification, Manufacturing & Scale-up), Application (CGT, Vaccines) - Global Forecast to 2029

  • Report
  • 344 Pages
  • Global
From
mRNA Synthesis Raw Material Market 2024-2028 - Product Image

mRNA Synthesis Raw Material Market 2024-2028

  • Report
  • 170 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.